urenco stable isotopes
Urenco Stable Isotopes supplies enriched and depleted stable and medical isotopes to industrial, medical, and research customers globally, using centrifuge technology to deliver ten isotope product lines in customized chemical forms from its Almelo, Netherlands facility.
- Company typePrivate
- Founded-
- HeadquartersAlmelo, Netherlands
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What urenco stable isotopes does
Urenco Stable Isotopes is a Netherlands-based division of Urenco Group that supplies enriched and depleted stable and medical isotopes to industrial, medical, and research customers worldwide. Headquartered in Almelo, the company operates as a premier European producer with over 30 years of operational history and leverages centrifuge technology originally developed for uranium enrichment to separate isotopes, achieving enrichment levels exceeding 99% or depletion below 1%. Its product portfolio spans ten core isotope families—Silicon, Zinc, Iridium, Germanium, Selenium, Xenon, Titanium, Molybdenum, Tellurium, and Tungsten—supplied in multiple chemical forms (oxide, metal, gaseous, elemental) and physical formats (cylinders, discs, pellets) tailored to customer specifications.
The company serves three primary customer segments: industrial users (nuclear reactor cooling with depleted zinc-64, non-destructive testing via iridium-192 and selenium-75, and semiconductor production with germanium-72 and silicon-28), medical and healthcare customers (diagnostic imaging, brachytherapy, cancer theranostics, and pain palliation—contributing to over 2 million patient treatments annually), and academic and research institutions (neutrino research, super-heavy element synthesis, food absorption studies, and material research). The go-to-market is enterprise field sales, with customers engaging from early R&D stages through commercial supply under custom quote-based pricing.
Revenue is generated through direct one-time sales of tailored isotope products and bespoke R&D-to-commercial solutions. Distribution is handled through direct global shipment under IATA, IMO, and ADR hazardous materials compliance. Strategic emphasis is on continuous portfolio expansion, including the co-development of a copper-64/67 theranostic pair with leading academic partners to capture growth in nuclear medicine. Urenco Stable Isotopes is privately held as a subsidiary of Urenco Group, which is owned by a consortium of European governments.
urenco stable isotopes firmographics
Firmographics- Name
- urenco stable isotopes
- Legal name
- Urenco Isotopes
- Website
- https://urencostableisotopes.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Urenco Stable Isotopes supplies enriched and depleted stable and medical isotopes to industrial, medical, and research customers globally, using centrifuge technology to deliver ten isotope product lines in customized chemical forms from its Almelo, Netherlands facility.
- Ownership category
- akta.pro rank
urenco stable isotopes industry classification
Industry- Product category
- Stable Isotope Production and Supply
- NAICS
- Other Basic Inorganic Chemical Manufacturing (325180), Basic Chemical Manufacturing (3251)
- SIC
- Industrial Inorganic Chemicals (2810)
- akta.pro primary industry
- Industrial Isotope Production & Supply (Co-60, Ir-192, Cs-137, Am-241, etc.) (EUAKAIAB)
- akta.pro secondary industry
- Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA)
Keywords
Where urenco stable isotopes is headquartered
LocationHeadquarters
- HQ city
- Almelo
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
urenco stable isotopes business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Infrastructure, Personnel, Operations, Supply Chain
Revenue model
- Stable and Medical Isotope Sales: Direct sales of enriched and depleted stable isotopes and medical isotopes to industrial, medical, and research customers. Products supplied in various chemical forms including oxide, metal, gaseous, elemental, and other forms in cylinders, discs or pellets.
- Custom Isotope Solutions: Bespoke isotope solutions developed in close cooperation with customers, from early R&D stages through to commercial supply, ensuring tailored products meeting specific quality and application standards.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom Quote-Based Pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
urenco stable isotopes product offering
Product offeringCore offering
Urenco Stable Isotopes supplies enriched and depleted stable and medical isotopes for industrial, medical, and research applications. Using advanced centrifuge technology originally developed for uranium enrichment, the company enriches isotopes to exceed 99% or depletes them below 1%, offering products in multiple chemical forms including oxide, metal, gaseous, and elemental configurations. The portfolio spans ten isotope product lines (Silicon, Zinc, Iridium, Germanium, Selenium, Xenon, Titanium, Molybdenum, Tellurium, and Tungsten) serving nuclear reactor cooling, non-destructive testing, semiconductor production, cancer diagnostics and therapy, and scientific research.
Product overview
Urenco Isotopes is a premier European stable and medical isotopes supplier that operates as a product portfolio company offering ten distinct isotope product lines (Silicon, Zinc, Iridium, Germanium, Selenium, Xenon, Titanium, Molybdenum, Tellurium, and Tungsten isotopes). Using advanced centrifuge technology, the company enriches materials to exceed 99% or depletes them below 1%, supplying isotopes in various chemical forms including oxide, metal, gaseous, elemental, and other configurations in cylinders, discs, or pellets. These isotope products serve three primary application domains: Medical (diagnostics, therapy, and pain relief including cancer treatment via theranostics), Industrial (nuclear reactor cooling, non-destructive testing, and semiconductor production), and Research (food uptake studies, material research, nuclear physics, and neutrino research). The company operates state-of-the-art facilities in the Netherlands and takes a personalized approach to partnerships, collaborating closely with customers to develop tailored isotope solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Silicon Isotopes Stable silicon isotopes enriched or depleted to any concentration, available in oxide, metal, gaseous, or elemental forms. Used in semiconductor production (silicon-28 enriched for improved thermal conductivity) and research applications.
- Zinc Isotopes Stable zinc isotopes including depleted zinc-64 for nuclear reactor cooling systems (reducing corrosion and cobalt-60 formation) and enriched zinc-68 for theranostics and cancer treatment, supplied in various chemical forms.
- Iridium Isotopes Stable iridium isotopes including iridium-191 (precursor for radioactive Ir-192) and iridium-192, used in non-destructive testing with high-specific-activity gamma radiation sources and in brachytherapy.
- Germanium Isotopes Stable germanium isotopes including germanium-72 for semiconductor pre-amorphization implant processes and germanium-76 for neutrino research, supplied in various chemical forms.
- Selenium Isotopes Stable selenium isotopes including selenium-74 for non-destructive testing gamma cameras and selenium-82 for neutrinoless double beta decay research, supplied in various chemical forms.
- Xenon Isotopes Stable xenon isotopes including xenon-124 (precursor for I-123 and I-125), xenon-129 for hyperpolarized MRI lung imaging, and xenon-136 for neutrino research, supplied in various chemical forms.
- Titanium Isotopes Stable titanium isotopes including titanium-50 for superheavy element synthesis and nuclear gamma resonance research, supplied in various chemical forms.
- Molybdenum Isotopes Stable molybdenum isotopes including molybdenum-98 for medical radionuclide production and molybdenum-100 for double beta decay research, supplied in various chemical forms.
- Tellurium Isotopes Stable tellurium isotopes including tellurium-123 and tellurium-124 as precursors for iodine-123 and iodine-124 PET imaging isotopes, supplied in various chemical forms.
- Tungsten Isotopes Stable tungsten isotopes including tungsten-186 (used to produce rhenium-188 for healthcare applications) and low-activating tungsten for fission and fusion reactors, supplied in various chemical forms.
Quantifiable outcome
- Over 2 million patient treatments per year supported by Urenco isotopes
- +2 more outcomes
Companies that use urenco stable isotopes
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
urenco stable isotopes technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
urenco stable isotopes partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Leading Academia (Undisclosed)coreUrenco Isotopes has established strategic partnerships with leading academic institutions to develop and commercialize the copper-64/67 theranostic pair. This breakthrough pairing offers unparalleled precision in both imaging and treatment for nuclear medicine applications, significantly enhancing patient outcomes.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
urenco stable isotopes competitors and assessment
Company assessmentOthers
- Centrus Energy: US-based uranium enrichment company using centrifuge technology originally licensed from Urenco. Operates adjacent centrifuge infrastructure in the same nuclear technology category; an enabling/ecosystem peer rather than a direct stable-isotope competitor.
Direct peers
- Nordion (Sotera Health): Canada-based supplier of medical isotopes and sterilization services, historically a major producer of Mo-99 and other reactor-based isotopes. Overlaps with Urenco in supplying isotopes to medical and industrial customers worldwide.
- Curium Pharma: Global nuclear medicine company producing diagnostic and therapeutic radiopharmaceuticals from reactor-produced isotopes. Comparable to Urenco in medical isotope supply, although Curium relies on reactor rather than centrifuge production methods.
- Eckert & Ziegler: German isotope technology company producing radioactive sources and radiopharmaceutical precursors for medical, industrial, and scientific use. Comparable to Urenco in industrial and medical isotope product portfolio, with similar European footprint.
- IRE (Institut National des Radioéléments): Belgium-based producer of medical radioisotopes for diagnostics and therapy, serving pharmaceutical companies and hospitals globally. Directly comparable to Urenco Stable Isotopes in isotope production for healthcare and life sciences applications, with overlapping customer base in nuclear medicine.
Emerging players
- ITM Isotope Technologies Munich: Munich-based radiopharmaceutical company producing medical radioisotopes (especially Lu-177 and Y-90) for cancer therapy. Emerging player in the same nuclear medicine supply chain that Urenco's medical-grade stable isotopes feed into.
- Telix Pharmaceuticals: Australia-listed biopharmaceutical company developing therapeutic and diagnostic radiopharmaceuticals using isotopes such as Lu-177 and Ga-68. Emerging player in theranostics with downstream demand for high-purity isotope precursors that Urenco can supply.
Broad incumbents
- Lantheus Holdings: US-listed radiopharmaceutical company with established diagnostic products (e.g., DEFINITY, Xenon-129 MRI gas) and pipeline in oncology therapeutics. Broad incumbent that overlaps with Urenco's medical isotope customers in nuclear imaging and therapy.
- Bayer (Radiology / Curadel JV): Bayer operates a contrast imaging and radiology business, including radiopharmaceutical partnerships, sitting adjacent to Urenco's medical isotope customers. Broad incumbent in pharmaceutical diagnostics with indirect overlap on stable precursor demand.
- GE HealthCare: Global medical imaging and pharmaceutical diagnostics company with a substantial radiopharma business producing PET and SPECT isotopes. Broad incumbent that overlaps with Urenco's customer base in nuclear medicine supply chains.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
urenco stable isotopes social profiles
Digital presenceurenco stable isotopes financial estimates
Financial estimateRevenue estimate
Valuation estimate
urenco stable isotopes leadership team
Management profileNumber of profiles
Profiles3 records
urenco stable isotopes funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
urenco stable isotopes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about urenco stable isotopes
What does urenco stable isotopes do?
Urenco Stable Isotopes supplies enriched and depleted stable and medical isotopes for industrial, medical, and research applications. Using advanced centrifuge technology originally developed for uranium enrichment, the company enriches isotopes to exceed 99% or depletes them below 1%, offering products in multiple chemical forms including oxide, metal, gaseous, and elemental configurations. The portfolio spans ten isotope product lines (Silicon, Zinc, Iridium, Germanium, Selenium, Xenon, Titanium, Molybdenum, Tellurium, and Tungsten) serving nuclear reactor cooling, non-destructive testing, semiconductor production, cancer diagnostics and therapy, and scientific research.
Is urenco stable isotopes a public or private company?
urenco stable isotopes is a private company. It is classified as state government owned and is currently operating.
When was urenco stable isotopes founded?
urenco stable isotopes was founded in -1.
Where is urenco stable isotopes based?
urenco stable isotopes is headquartered in Almelo, Netherlands, in the Europe region.
How does urenco stable isotopes make money?
Two revenue lines are on record. Stable and Medical Isotope Sales are the primary driver. The others are custom Isotope Solutions.
Who are urenco stable isotopes's main competitors?
Centrus Energy is listed as an others. Direct peers are Nordion (Sotera Health), Curium Pharma, Eckert & Ziegler and IRE (Institut National des Radioéléments). Emerging players are ITM Isotope Technologies Munich and Telix Pharmaceuticals. Broad incumbents are Lantheus Holdings, Bayer (Radiology / Curadel JV) and GE HealthCare.
Does urenco stable isotopes have an API?
No public API is recorded for urenco stable isotopes.
What industry is urenco stable isotopes in?
urenco stable isotopes's product category is Stable Isotope Production and Supply. Its primary akta.pro industry code is EUAKAIAB, Industrial Isotope Production & Supply (Co-60, Ir-192, Cs-137, Am-241, etc.), with a secondary code of EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.). Its NAICS code is 325180 and its SIC code is 2810.